Background

The delivery of gene constructs into animal cells is an indispensible tool for conducting various biomedical studies and producing transgenic animals. However, several aspects should be taken into consideration for successful transgene expression in target cells. The extent of transgene expression largely depends on multiple aspects, such as gene delivery method, cellular physicochemical properties, and the traits of the construct [1]. Although methods for gene transfer into the host cells are currently standarized in several cell types, the transfection efficiency remains unsatisfactory in many cases and efforts to devise an optimal construct that can induce constant expression have not been very promising. In addition, many obstacles, such as transgene silencing and variegation, have yet to be overcome to enhance transgene expression [2].

To date, various strong enhancers/promoters have been used for stable expression of transgenes in animal cells. Among these, the cytomegalovirus (CMV) immediate-early enhancer/promoter and CAG (CMV enhancer with a chicken beta-actin transcription start site and a rabbit beta-globin intron) promoters have been used in a variety of cells due to their ability to induce immediate and strong transcription [3, 4]. However, the two promoters exhibit different transcriptional activities, presumably due to distinctive constituents [57]. Other studies have also shown transcriptional variation among different tissues or developmental stages [811].

Other transcription regulator elements have also been used to sustain transcription activity. Chicken 5'-DNase I-hypersensitive sites 4 (cHS4), derived from the chicken beta-globin locus, contains GC-rich DNA sequences and a CTCF-dependent element linked to the nuclear matrix [12, 13]. It enhances transgene expression in cultured cells [14] and transgenic animal cells [15], and prevents silencing of viral vectors [16, 17]. The woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) is derived from the 3' untranslated region (3' UTR) of viral RNA [18] and acts as a posttranscriptional enhancer by stimulating the cytoplasmic import of mRNAs [19, 20]. The matrix attachment region (cMAR) from the 5' regulatory region of the chicken lysozyme gene contains AT-rich sequences and enhances transgene expression in various immortalized cells [21, 22], transgenic animals [23, 24], and plants [25].

Birds serve as excellent models of disease and bioreactor production due to the ease of embryo manipulation and the availability of various transgenic technologies using primordial germ cells and testicular cells [26]. However, only a limited number of recently refined constructs carrying transcription activators have been used for inducing stable gene expression in transgenic birds. Therefore, we evaluated whether these multiple transcription regulators can help maintain stable gene expression in chicken cells, and propose an optimal construct with an optimal combination of promoter/enhancer and transcription regulatory units.

Results

Correlation between size and copy number of the delivered plasmids

Given that each vector contained different promoters and cis-acting elements, their sizes were variable (Fig. 1). Therefore, we examined the relationship between vector size and the integrated vector copy numbers. Relative vector copy numbers were generally reduced as vector size increased (R2 = 0.701; Fig. 2).

Figure 1
figure 1

Construction of the vectors containing different cis -regulatory elements. CMV, human cytomegalovirus immediate-early enhancer/promoter; CAG, CMV enhancer + chicken beta-actin promoter + rabbit beta-globin intron; eGFP, enhanced green fluorescent protein; pA, bovine growth hormone polyadenylation signal; cMAR, chicken lysozyme matrix attachment region (BamHI-PvuI fragment); cHS4, the core region of chicken beta-globin insulator (250bp); WPRE, woodchuck hepatitis virus posttranscriptional regulatory element.

Figure 2
figure 2

Correlation between relative copy number and vector size. Relative vector copy number, analyzed by real-time PCR, decreased exponentially as vector size increased. The graph and R2 were created with Microsoft Office Excel.

CMV and CAG promoter transcription activities differ in chicken embryonic fibroblasts

To compare the strength of the CMV and CAG promoters, mRNA levels were measured by real-time PCR. MFI was analyzed by flow cytometry to study transgene expression levels induced by the CMV and CAG promoters in DF-1 cells. The difference in mRNA expression levels between the CMV and CAG promoters was not significant (P = 0.35), whereas the MFI of the CAG promoter (pAeG) was 1.6-fold higher than that of the CMV promoter (pCeG) (P = 0.027; Fig. 3a, b). When HS4 was juxtaposed to the 5' and 3' regions of the transgene cassette, the difference in mRNA levels and MFI values between the two promoters was not significant (P > 0.05; Fig. 3a, b). However, the transcript level generated by the CAG promoter was 1.5-fold higher than that generated by CMV in MAR-flanked plasmids (pCeGM versus pAeGM, P = 0.0439; Fig. 3a).

Figure 3
figure 3

Analysis of eGFP expression driven by CMV or CAG promoter in DF-1 cells. The effect of various cis-acting elements on eGFP expression were analyzed in both mRNA (a) and protein (b) levels. A significant model effect was found on both mRNA and MFI (both P < 0.0001). Means with different superscripts (a, b, c, d, e, f) differ significantly (P < 0.05; F values = 15.80 and 67.51 in mRNA and protein level analysis, respectively; total degree of freedom = 23). Data represent the mean of three replicates, and error bars indicate ± S.D. (n = 3 in each plasmid).

cMAR and cHS4 enhance transgene expression

Both cMAR and cHS4 increased eGFP expression in mRNA and protein (Fig. 3a, b). The CMV promoter led to increases of 2.9-fold and more than 3.0-fold in mRNA (P = 0.0052) and MFI (P < 0.0001), respectively, in pCeGIN compared to those of the control pCeG. Adding cMAR (pCeGM) yielded an approximately 2.6-fold increase in mRNA expression level (P = 0.018) and 3.5-fold increase in MFI value (P < 0.0001) relative to pCeG. The CAG promoter led to increases of 2.1-fold (P = 0.0086) and 1.9-fold (P = 0.0001), respectively, in the HS4-flanked plasmid (pAeGIN) compared to the control pAeG. Likewise, cMAR led to increases of 2.5-fold (P = 0.0014) and 2.1-fold (P < 0.0001), respectively, in pAeGM compared to pAeG. To investigate the effects of cHS4 and cMAR on eGFP expression at the single-cell level, flow cytometry was performed. A considerable proportion of the cells with transgene suppression were noted in control plasmids (Fig. 4a, arrows); however, adding cHS4 or cMAR clearly reduced the level of such heterogeneity. Furthermore, the coefficient of variation (CV) of eGFP-expressing cells was reduced in the vector with cHS4 and cMAR (P < 1 × 10-5; Fig. 4b).

Figure 4
figure 4

Flow cytometry analysis of electroporated DF-1 cells. (a) The proportion of eGFP-expressing cells are indicated. Arrows denote cells of the non-expressing population. (b) The effect of cis-acting elements on the coefficient of variation (CV) in eGFP expression driven by CMV and CAG promoters. A significant model effect was found on CV among the eight constructs (P < 0.0001). Means with different letters (a, b, c, d, e, f, g) differ significantly (P < 0.05; F value = 2927.53; total degree of freedom = 23). Data represent the mean of three replicates, and error bars indicate ± S.D.(n = 3 in each plasmid).

The effect of WPRE is promoter-dependent

pCeGMW increased eGFP expression in both mRNA (2.4-fold, P < 0.0001) and MFI (1.7-fold, P < 0.0001) compared to the control pCeGM (Fig. 3a, b). With the CAG promoter, pAeGMW did not induce a dramatic increase in mRNA level (P = 0.1482), whereas an increase was noted in the MFI compared to pAeGM (1.2 folds, P = 0.0238). The level of transcription silencing in each construct was then analyzed by flow cytometry, which revealed an increase in the proportion of eGFP-positive cells in HS4-, MAR-, and MAR+WPRE-inserted constructs compared to those transfected with control plasmids (pCeG and pAeG). However, in pAeGMW, the eGFP-positive population decreased compared to those of pAeGM and pAeGIN. A significant model effect was found on the CV of eight constructs that were tested (P < 0.0001). Generally, the CAG promoter constituted less heterogeneity in eGFP expression compared to CMV, except in the construct with MAR and WPRE, for which the CV of CAG (pAeGMW) was higher than that of CMV (pCeGMW, Fig. 4b).

Discussion

Birds are an excellent model for studying transgenic animals and disease because of their physiological uniqueness during embryogenesis [2629]. Various methods for producing transgenic birds have been developed over the last two decades [3033] however, optimized gene constructs are lacking. Therefore, to develop an efficient non-viral vector system in chicken, we examined three regulatory elements for high transgene expression: (1) promoter/enhancer elements, (2) cis-acting elements for blocking the position effect, and (3) posttranscriptional elements associated with RNA processing.

We described and compared the role of the various cis-acting elements as well as the efficacy of combinatorial regulatory elements to allow for enhanced regulation of transfected genes. To identify optimal combinations of cis-acting elements for efficient transgene expression, we constructed eight non-viral vectors containing various cis-regulatory elements. Furthermore, we compared the CMV and CAG promoters to identify the most appropriate promoter for enhancing transgene expression. Considering the position effects caused by the chromosomal environment in the host cells, cMAR and cHS4 derived from chicken genomic sequences were tested. In addition, WPRE was inserted into the downstream region of the open reading frame of the eGFP gene to increase transgene expression levels via post-transcriptional regulation of transcripts.

The relative vector copy numbers decreased as vector size increased, which has also been reported in previous studies. For example, the gene-transfer capacity of plasmid DNA has been shown to be inversely related to the vector size, and furthermore, gene expression decreases as the size of DNA increases [34, 35]. Given that the electroporation performed in the present study contributed to the delivery of plasmid DNA into the cytoplasm, our results may be due to a decrease in DNA diffusion mobility from the cytoplasm to the nucleus as the vector size increased [36, 37].

The CAG promoter was more effective than the CMV promoter for transgene expression in DF-1 cells, possibly due to differences in the promoter constituents. The CMV promoter originated from the immediate-early gene of human CMV did not contain the intron sequence [38], whereas the CAG promoter consisted of the same CMV immediate-early enhancer with a chicken beta-actin promoter and rabbit beta-globin intron [5]. The presence of an intron in the promoter affects transgene expression in mammalian cells [5], and inserting a large CMV intron and beta-actin intron into plasmids with the same promoter increases luciferase activity [6]. Therefore, our results support previous studies showing the roles of the chicken beta-actin promoter and rabbit beta-globin introns in the CAG promoter in improving the efficiency of transgene expression [5].

The chicken HS4 insulator, which contains a CTCF-binding site, enters the nuclear matrix and forms nucleosome gaps by binding with CTCF [39]. The expression of the transgene cassette flanked by the HS4 insulator is not affected by other neighboring chromosomal elements such as enhancers [40]. The MAR element, which consists of AT-rich DNA, makes an independent loop or domain in the chromatin by binding to nuclear matrix proteins such as topoisomerase II, histone H1, lamins, SP120, ARBP, and SATB1. Using this mechanism, interferences with chromosomal structures surrounding the gene cassettes are blocked, thereby enhancing the binding of the transcription factor to the regulatory region [41]. In the present study, we also found that cHS4 and cMAR increased the number of transfected cells and reduced variation in eGFP expression. Therefore, our data indicate that 2× cHS4 and cMAR prevent position effects that exert an inhibitory effect on transgene expression in chicken cells.

WPRE, which is associated with RNA processing, has a pivotal regulatory element for efficient transgene expression. It can enhance transgene expression related to splicing and polyadenylation, export it into the cytoplasm, and stabilize the mRNA transcript [18]. When combined with the appropriate regulatory elements, WPRE promotes the cytoplasmic export of nuclear mRNA without introns [42, 43]. In addition, when inserted into the 3' UTR of non-viral vectors, it increases transgene expression in mammalian cells [44]. Our current results showed that WPRE improves eGFP expression driven by CMV and CAG promoters in DF-1 cells. However, this effect is promoter-dependent. When WPRE was added, the increase in eGFP expression was higher in the vector combined with the CMV promoter than with CAG. These results support the idea that the effect of WPRE depends on what constitutes the promoter [45].

We have produced germline chimeric chicken [4649] and quail [50, 51] using various types of germ cells to establish avian transgenesis. Among various donor cells that generate chimeras, the potential of primordial germ cells (PGCs) is limitless based on their ability to migrate towards the sex cord in the recipient embryo, and subsequent testcross analyses allows the production of donor-derived offspring. However, there are several obstacles to this process because germ cells are relatively transcriptionally quiescent and prone to switching off transgene expression [52, 53]. Our results can be directly applied to genetic and cellular manipulation systems for transgenesis via an increase in transcription activity, thus preventing position effects provoked by nearby enhancers/suppressors and increasing cytoplasmic export of transcripts by stabilizing mRNA.

Conclusions

The purpose of this research was to develop a non-viral vector system with minimized transgene silencing in chicken cells. The application of cHS4 and cMAR effectively reduced the silencing of transgene expression, while WPRE enhanced the expression level. Our data constitute optimized regulatory elements that can be used to induce stable gene expression and study gene function in chicken. The present research also provides new insights to establish the bioreactor and model bird production system using avian transgenic technology.

Methods

Vector construction

To construct pCeG, the EcoR I-Xba I fragment of eGFP from pEGFP-1 (Clontech, Mountain View, CA) was inserted into pcDNA3 (Invitrogen, Carlsbad, CA) containing the CMV promoter (Fig. 1). To construct pAeG, the Spe I-EcoR I fragment of the CAG promoter from pCAGGS [5] was inserted into pCeG. The BP-MAR fragment [54] was derived from the PCR product of chicken genomic DNA using the primer set P1 (5'-CGC TCT AGA ACT AGT GGG ATC CAT-3') and P2 (5'-ATG CCT GTT GCA GCT GTT TAC G-3'), which was then inserted into Bgl II and Dra III sites of pCeG and pAeG, thus constructing pCeGM and pAeGM, respectively. pCeGIN and pAeGIN were constructed inserting the tandem-duplicated cHS4 (2×HS4) fragment, which was amplified from chicken genomic DNA using P3 (5'-GCA GGT TTC CTG GAA GGT-3') and P4 (5'-AGC TAA AGC TTT TTC CGT-3') primers, into Bgl II and Dra III sites of pCeG and pAeG, respectively [55]. To construct pCeGMW and pAeGMW, the WPRE fragment was amplified from pWPI by PCR using P5 (5'-GCG GCC GCG ACC TCG AGG GAA TTC CGA T-3') and P6 (5'-GCG GCC GCT TCG AAG CTT GAC GAA TTC C-3') primers. The PCR product was then inserted into a Not I site of pCeGM and pAeGM. A schematic diagram of the vectors is illustrated in Figure 1.

Cell culture and transfection

DF-1 (ATCC, Manassas, VA, Cat. No. CRL-12203) cells were cultured in Dulbecco's Modified Eagle medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS, Invitrogen) and 1× antibiotic-antimycotics (Invitrogen) in an incubator at 37°C and 5% CO2 in an air atmosphere with 60-70% relative humidity. Transfection was performed as described previously [56]. Briefly, a total of 1×106 of cells were suspended in serum-free OPTIMEM-I (Invitrogen) with the same molar ratio of linearized plasmid DNAs in a 0.4-cm cuvette (Bio-Rad, Hercules, CA) and electroporation was performed using Gene Pulser Xcell™ (Bio-Rad). The transfected cells were selected with 400 μg/ml G418 (Invitrogen) for 21 days and cultured at least 90 days before further analysis. Three cell lines in each plasmid were subjected to analysis of eGFP expression.

Quantitative real-time PCR

Total RNA was isolated from G418-selected cells using TRIZOL® Reagent (Invitrogen). cDNA was synthesized using the SuperScript® III First-Strand Synthesis kit (Invitrogen) according to the manufacturer's protocol. Genomic DNA was extracted from cells using Wizard® SV Genomic DNA purification system (Promega, Madison, WI) according to the manufacturer's instructions. The expression level of mRNA from the cells electroporated with various constructs were compared to those with pCeG and measured in triplicate using real-time PCR (ABI 7300 Real-Time PCR system, Applied Biosystems, Foster City, CA) and SYBR® Green (Sigma, St. Louis, MO). To measure and compare relative mRNA expression levels, the measured values were divided by the copy numbers of their relative vectors [45, 54]. The primers used for quantitative PCR were eGFP-forward (5'-TCA AGG ACG ACG GCA ACT ACA A-3'), eGFP-reverse (5'-GAT GGG GGT GTT CTG CTG GT-3'), GAPDH-forward (5'-TCA CAG CCA CAC AGA AGA CGG-3'), and GAPDH-reverse (5'-CAG ACG GCA GGT CAG GTC AA-3'). Relative quantification of mRNA expression was calculated using the 2-ΔΔCt method [57].

Flow cytometry

Flow cytometry was performed using a FACS Calibur™ flow cytometer (BD Biosciences, San Jose, CA) and CellQuest software (BD Biosciences) equipped with a standard fluorescence filter set. Trypsinized cells were resuspended in phosphate buffered saline (PBS, Invitrogen) supplemented with 3% FBS. The mean fluorescence intensity (MFI) and coefficient of variation (CV) were also obtained by flow cytometry.

Statistical analysis

Data were subjected to analysis of variance (ANOVA) according to the general linear model (PROC-GLM) of the SAS program (SAS Institute, Cary, NC). If the main effect was significant, treatment effects were compared by the least squares method. P-values of less than 0.05 were considered statistically significant.